Update on treatment of CMV retinitis.
Feinberg
J
J
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000284:Administration, Oral; D000077404:Cidofovir; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004343:Drug Implants; D005123:Eye; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D004343:Drug Implants; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir; D015774:Ganciclovir